<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1388</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2009</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<volume>23</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Comparison of the effects of low calorie diet and lovastatin on serum lipoproteins, apob, homocysteine and total antioxidant capacity in hyperlipidemic obese persons</title>
	<subject_fa>Nutrition</subject_fa>
	<subject>Nutrition</subject>
	<content_type_fa>Original Research</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt; &lt;strong&gt; Abstract &lt;/strong&gt;&lt;/p&gt;&lt;p&gt; &lt;strong&gt; Background: &lt;/strong&gt;obesity is directly related to dyslipidemia which contributes significantly &lt;/p&gt;&lt;p&gt;  to the risk of coronary heart disease, a major cardiovascular disease and a serious &lt;/p&gt;&lt;p&gt;  health problem. The aim of this study was to compare the effects of low calorie &lt;/p&gt;&lt;p&gt;  diet and those of lovastatin on serum lipoproteins, apo B, homocysteine, and total antioxidant capacity (TAC) in hyperlipidemic obese patients. &lt;/p&gt;&lt;p&gt; &lt;strong&gt; Methods: &lt;/strong&gt;In a randomized clinical trial, 41 obese patients were stratified by BMI, &lt;/p&gt;&lt;p&gt;  serum triglyceride (TG) and total cholesterol (TC) and randomly allocated to one of &lt;/p&gt;&lt;p&gt;  these groups: 1- Lovastatin tablet (40mg) 2-1200 calorie diet per day according to the &lt;/p&gt;&lt;p&gt;  therapeutic lifestyle change (TLC) dietary pattern for 8 weeks. Serum lipoprotein, &lt;/p&gt;&lt;p&gt;  apo B, homocysteine, and TAC were measured enzymatically, immunoturbidometrically, &lt;/p&gt;&lt;p&gt;  via EIA , and colorimetrically respectively. &lt;/p&gt;&lt;p&gt; &lt;strong&gt; Results: &lt;/strong&gt;There were a significant decrease in mean of the serum TC (P=0.0001), &lt;/p&gt;&lt;p&gt;  LDL- c(p=0.0001), TG/HDL-c(p=0.03), apoB (p=0.0001) and significant increase &lt;/p&gt;&lt;p&gt;  in TAC (p=0.0001) in diet group at the end of the study compare to lovastatin group. &lt;/p&gt;&lt;p&gt;  TC, LDL-c, TG, LDL-c/HDL-c , TC/HDL-c , TG/HDL-c, homocysteine and apo B &lt;/p&gt;&lt;p&gt;  showed significant decrease but TAC showed significant increase in the diet group at &lt;/p&gt;&lt;p&gt;  the end of the study compared to beginning values (p=0.0001, p=0.0001, p=0.0001, &lt;/p&gt;&lt;p&gt;  p=0.001, p=0.0001, p=0.0001, p=0.0001, p=0.0001 and p=0.002, respectively). But &lt;/p&gt;&lt;p&gt;  in the lovastatin group only TC, LDL-C, TG, LDL-c/HDL-c, TC/HDL-c and apo B &lt;/p&gt;&lt;p&gt;  had significant decrease at the end of the study compared to beginning values &lt;/p&gt;&lt;p&gt;  (P=0.0001, P=0.0001, P=0.0001, P=0.01, P=0.02, P=0.002, respectively) &lt;/p&gt;&lt;p&gt; &lt;strong&gt; Conclusion: &lt;/strong&gt;The study revealed that when compared to levostation 1200 kcal diet &lt;/p&gt;&lt;p&gt;  according to TLC dietary pattern had more beneficial effects on serum lipoproteins, &lt;/p&gt;&lt;p&gt;  apo B, homocysteine and TAC, so it may decrease CVD risk factors and mortality &lt;/p&gt;&lt;p&gt;  in hyperlipidemic obese patients. &lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>obesity, lipoprotein, lovastatin, low calorie diet, apo B.</keyword>
	<start_page>14</start_page>
	<end_page>22</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1-35&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Farzad</first_name>
	<middle_name></middle_name>
	<last_name>Shidfar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>farzadshidfar@yahoo.com      </email>
	<code>20031947532846001749</code>
	<orcid>20031947532846001749</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>School of Health, Iran University of Medical Sciences.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Javad</first_name>
	<middle_name></middle_name>
	<last_name>Haji Miresmail</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846001750</code>
	<orcid>20031947532846001750</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>School of Medicine, Iran University of Medical sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Sharieh</first_name>
	<middle_name></middle_name>
	<last_name>Hosseini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846001751</code>
	<orcid>20031947532846001751</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Islamic Azad University, Sari Branch, Sari, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Shahrzad</first_name>
	<middle_name></middle_name>
	<last_name>shidfar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846001752</code>
	<orcid>20031947532846001752</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>University of Massachausetts, Memorial Hospital,Worcester, USA.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Reza</first_name>
	<middle_name></middle_name>
	<last_name>Homayonfar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846001753</code>
	<orcid>20031947532846001753</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>,School of Health, Iran University of Medical Sciences,Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
